Arrowhead Pharmaceuticals Inc. (ARWR)

30.88
NASDAQ : Health Technology
Prev Close 32.12
Day Low/High 30.71 / 32.73
52 Wk Low/High 10.41 / 35.41
Avg Volume 1.79M
Exchange NASDAQ
Shares Outstanding 95.30M
Market Cap 3.06B
EPS -0.70
P/E Ratio 69.83
Div & Yield N.A. (N.A)

Arrowhead Lead Scientific Advisor, Dr. Mauro Ferrari And Calando Pharmaceuticals’ SiRNA Drug Delivery Platform Featured In Houston Chronicle

Arrowhead Research Corporation (NASDAQ:ARWR) today announced that two articles of interest to Arrowhead stockholders appeared in the Houston Chronicle this week.

Unidym And Guardian Industries Form Partnership To Develop And Commercialize Carbon Coated Glass Products

Unidym, a majority owned subsidiary of Arrowhead Research (NASDAQ: ARWR), announced today that it has entered an agreement with global glass manufacturer Guardian Industries to develop and commercialize carbon coated...

Arrowhead Reports Fiscal 2010 Second Quarter Financial Results

Arrowhead Research Corporation (NASDAQ: ARWR) today announced financial results for its fiscal 2010 second quarter ended March 31, 2010.

Arrowhead Research To Report Second Quarter Fiscal 2010 Financial Results And Host Conference Call On Thursday, May 13, 2010

Arrowhead Research Corporation (NASDAQ: ARWR) today announced that it will report its financial results for the fiscal 2010 second quarter ended March 31, 2010, on Thursday, May 13, 2010, at 4:30 p.

Arrowhead Announces The Appointment Of Former FDA Commissioner And National Cancer Institute Director Dr. Andrew Von Eschenbach To Its Board Of Advisors

Arrowhead Research Corporation (Nasdaq: ARWR) announced today the appointment of Dr.

Arrowhead To Present At Upcoming Investor Conferences

Arrowhead Research Corporation (Nasdaq:ARWR) announced today that Dr.

Arrowhead Regains Compliance With Rule 5550, NASDAQ $1.00 Minimum Bid Requirement

Arrowhead Research Corporation (NASDAQ: ARWR) today announced that, on April 14, 2010, it received a notification from the NASDAQ Stock Market indicating that the Company has regained compliance with NASDAQ Rule...

CNT-Enabled Touch Sensitive MP-4 Players Based On Unidym’s Printable CNT Films Displayed At China Electronics Fair

Unidym, a majority owned subsidiary of Arrowhead Research Corporation (NASDAQ:ARWR), announced today that touch sensitive MP-4 players enabled by Unidym’s transparent conductive films were displayed at the 75 th ...

Arrowhead Announces The Appointment Of Nobel Laureate Dr. Leland Hartwell To Its Board Of Advisors

Arrowhead Research Corporation (Nasdaq:ARWR) announced today the appointment of Dr.

Arrowhead Research, Verenium: Early Volume Plays

Several stocks trading near $5 were poised to move on above-average volume during Monday's session.

Arrowhead Research Subsidiary, Calando Pharmaceuticals, Provides First Proof Of RNA Interference In Humans With Systemically Administered SiRNA Therapeutic; Clinical Trial Results Published In Nature

Arrowhead Research Corporation (NASDAQ: ARWR) today announced that the clinical trial being conducted by majority-owned subsidiary, Calando Pharmaceuticals, Inc.

Arrowhead Receives Additional 180-Day Grace Period To Comply With The NASDAQ $1.00 Minimum Bid Requirement

Arrowhead Research Corporation (NASDAQ: ARWR) today announced that, on March 16, 2010, it received a notification from the NASDAQ Stock Market indicating that the Company will have an additional 180-day grace period,...

Arrowhead Reports Fiscal 2010 First Quarter Financial Results

Arrowhead Reports Fiscal 2010 First Quarter Financial Results

Arrowhead Research Corporation (NASDAQ: ARWR) today announced financial results for its fiscal 2010 first quarter ended December 31, 2009.

Arrowhead Research To Report First Quarter Fiscal 2010 Financial Results And Host Conference Call On Thursday, February 11, 2010

Arrowhead Research Corporation (NASDAQ: ARWR) today announced that it will report its financial results for the fiscal 2010 first quarter ended December 31, 2009, on Thursday, February 11, 2009 at 4:30 p.

Unidym Adds Malcolm Gillis, Ph.D. To Board Of Directors

Unidym, Inc., a majority owned subsidiary of Arrowhead Research Corporation (NASDAQ:ARWR), today announced that Malcolm Gillis, Ph.

Arrowhead Appoints Chief Financial Officer

Arrowhead Research Corporation (NASDAQ:ARWR) today announced that Ken Myszkowski has been appointed as the Company’s Chief Financial Officer.

Amicas, Limelight: Early Volume Plays

Amicas, Limelight: Early Volume Plays

Several stocks trading near $5 were poised to move on above-average volume during Monday's session.

Friday's ETF Winners & Losers

Friday's ETF Winners & Losers

Funds tracking metals and mining are declining.

Thursday's Small-Cap Winners & Losers

Thursday's Small-Cap Winners & Losers

Tweeter Home Entertainment climbs on news of a restructuring plan.

Friday's ETF Winners & Losers

Chip funds are strong.

Friday's ETF Winners & Losers

Oil-related funds are strong performers.

Tech Stocks in Motion

Antenna maker Phazar soars 50% after posting higher second-quarter results.

TheStreet Quant Rating: C+ (Hold)